DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN)

CUSIP: 253748206

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
4,056
Share change
+4,056
Total reported value
$9,000
Price per share
$2.21
Number of holders
4
Value change
+$9,000
Number of buys
4

Quarterly Holders Quick Answers

What is CUSIP 253748206?
CUSIP 253748206 identifies DFFN - DIFFUSION PHARMACEUTICALS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) as of Q4 2016

As of 31 Dec 2016, DIFFUSION PHARMACEUTICALS IN - COM NEW (DFFN) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,056 shares. The largest 4 holders included Advisor Group, Inc., PNC FINANCIAL SERVICES GROUP, INC., UBS Group AG, and Tower Research Capital LLC (TRC). This page lists 4 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.